Geron Corporation's Rytelo gains FDA approval for MDS treatment, with promising sales and positive analyst outlook. Click ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...
Q3 2024 Earnings Call Transcript November 7, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.04, ...
RYTELOâ„¢ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent ...
2d
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...
Leading GCC in IT services, MDS SI Group accelerates growth through strategic acquisitions Dubai: MDS System Integration (SI) Group continues to solidify its leadership in the GCC’s IT services ...
The Colgate Keep India Smiling Scholarship 2024 is now open for applications from BDS and MDS students across India. Offering a one-time financial award of INR 75,000, the scholarship supports ...
The Medical Counselling Committee (MCC) has announced the NEET MDS Counselling 2024 special stray vacancy round allotment result. Candidates can check their allotment results on the official ...
First patient dosed with first-in-class SMARCA2(BRM) selective inhibitor FHD-909 (LY4050784) in Phase 1 trial with primary target population in ...
(MENAFN- Pro Global) MDS System Integration (SI) Group continues to cement its leadership in the GCC’s IT services industry, with the latest IDC Semiannual Services Tracker 2023H2 ranking the ...
Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET. Company Participants. Chris Taylor - Vice President, Investor Relations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback